Cleared Traditional

K001522 - TRANSQ3

K001522 is an FDA 510(k) clearance for TRANSQ3, manufactured by Iomed, Inc.. The device is a Class 2 Physical Medicine device with product code KTB cleared through the Traditional 510(k) pathway after a 155-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2000
Decision
155d
Days
Class 2
Risk

K001522 is an FDA 510(k) clearance for the TRANSQ3. Classified as Device, Iontophoresis, Specific Uses (product code KTB), Class II - Special Controls.

Submitted by Iomed, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on October 18, 2000 after a review of 155 days - an extended review cycle.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5525 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all Iomed, Inc. devices

FDA 510(k) Submission Details - K001522

510(k) Number K001522 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 16, 2000
Decision Date October 18, 2000
Days to Decision 155 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d slower than avg
Panel avg: 115d · This submission: 155d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KTB Device Classification - Class 2, Special Controls

Product Code KTB Device, Iontophoresis, Specific Uses
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.5525
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Peers - KTB Device, Iontophoresis, Specific Uses

All 8
Devices cleared under the same product code (KTB) and FDA review panel - the closest regulatory comparables to K001522.
Macroduct Advanced Model 3710
K180627 · Elitechgroup, Inc. · Jul 2018
RH-950
K033192 · Iomed, Inc. · Dec 2003
RH-900
K031115 · Iomed, Inc. · Jul 2003
PHORESOR MODEL PM2000
K001410 · Iomed, Inc. · Aug 2000
PHORESOR II, MODEL PM900
K974855 · Iomed, Inc. · Mar 1998
TRANSQ ELECTRODE PHORESOR II
K954126 · Iomed, Inc. · Jan 1996